|drug905||Conventional medicines (Oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir) Wiki||1.00|
There is one clinical trial.
The aim of this study is to test whether Traditional Chinese Medicines (TCMs) are effective and safe for treating COVID-19 infection. After the enrolment of approximately 30 subjects, the recruitment will be paused, and planned interim analysis will be performed to preliminarily investigate the efficacy and safety of TCMs in patients infected with COVID-19.
Description: The incidence rate of acute respiratory distress syndrome (ARDS) developmentMeasure: The incidents of acute respiratory distress syndrome (ARDS) development Time: 14 days
Description: Time to complete remission of fever in eligible subjectsMeasure: The time to fever resolution rate Time: 14 days
Description: improvement of chest radiographic evidence indirectly reflects recovery in patients infected with COVID-19.Measure: Time to recovery of lung injury Time: 14 days
Description: The rate of subject who die will be described.Measure: Rate of subjects who die Time: 28 days
Description: The rate of subjects with severe 2019-nCoV infection who receive systematic corticosteroids will be described.Measure: Rate of subjects receiving systematic corticosteroids Time: 28 days
Description: The length of hospital staysMeasure: The length of hospital stays Time: 28 days
Description: The duration of respiratory support including invasive and non-invasive mechanical ventilationMeasure: The duration of respiratory support Time: 28 days
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports